ICO-33

N/A

Report date: 2024/07/30 10:23:43

Base Information

Drug NameICO-33
Drug Alias NameICO-33
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionGlucose transporter 1 inhibitors
TargetsGlucose transporter 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEstonia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIcosagen Cell Factory OU
China Registration ClassN/A

Develop Information

Active CompaniesIcosagen Cell Factory OU
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A